I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Mesenchymal Stem Cells Market on a Rapid Growth Path
Recent Market Activity
Current and Future Analysis
The Present and Future of MSC Therapies
Select MSC-based Therapeutics
Mesenchymal Stem Cell Research
Completed Phase III Studies with MSCs
MSCs are Being Explored for Several New Treatment Possibilities
Widespread Commercialization of 'Off-the-Shelf' MSCs to Become
a Reality
Software Companies Endeavour to Cash in on the Boom
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS
Cell Applications, Inc. (USA)
Celprogen, Inc. (USA)
Cyagen US Inc. (USA)
Genlantis, Inc. (USA)
Lonza Group (Switzerland)
Mesoblast Limited (Australia)
MilliporeSigma (USA)
Neuromics (USA)
Orthofix International N.V. (Italy)
PromoCell GmbH (Germany)
R&D Systems, Inc. (USA)
ScienCell Research Laboratories (USA)
Stemcell Technologies Inc. (Canada)
Stemedica Cell Technologies, Inc. (USA)
Thermo Fischer Scientific, Inc. (USA)
Vitro Biopharma (USA)

3. MARKET TRENDS & DRIVERS
Development of Regenerative Medicine Accelerates Demand for MSCs
Ageing Demographics to Drive Demand for Mesenchymal Stem Cell
Therapies
Global Aging Population Statistics - Opportunity Indicators
Growing Prevalence of Chronic Diseases Propels Demand for
Mesenchymal Stem Cells
Key Disease Statistics - Opportunity Indicators
Growing Volume of Orthopedic Procedures: An Opportunity for the
MSC Market
Adult Stem Cell Therapies on Growth Trajectory, as
Controversies Continue to Haunt Embryonic Stem Cell Research
Adult Stem Cells and Embryonic Stem Cells - A Comparison
MSCs Versus Embryonic or Induced Pluripotent Stem Cells
MSC Therapies - Immune to Ethical Issues Applicable to
Embryonic Stem Cells
MSCs - A Potential Vehicle for 'Targeted Drug Delivery'
Stem Cell Based Bone Grafts: Promising Growth Ahead
Loopholes Associated with In Vivo Properties Constrain
Therapeutic Advancements
Major Challenges Confronting Mesenchymal Stem Cell Market
Allogeneic MSCs - Offering Promise in Immunosuppressive and
Tissue Repair Therapy
Administration Route Determines the Effectiveness of MSCs

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Mesenchymal Stem
Cells (MSC) by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 2: World Historic Review for Mesenchymal Stem Cells (MSC)
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 3: World 15-Year Perspective for Mesenchymal Stem Cells
(MSC) by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Human MSC by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 5: World Historic Review for Human MSC by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Human MSC by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 7: World Current & Future Analysis for Mouse MSC by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 8: World Historic Review for Mouse MSC by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Mouse MSC by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 10: World Current & Future Analysis for Rat MSC by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 11: World Historic Review for Rat MSC by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Rat MSC by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 13: World Current & Future Analysis for Other Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 14: World Historic Review for Other Types by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Other Types by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Research
Institutes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 17: World Historic Review for Research Institutes by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Research Institutes by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Hospitals by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 20: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 22: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 23: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 25: USA Current & Future Analysis for Mesenchymal Stem
Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 26: USA Historic Review for Mesenchymal Stem Cells (MSC)
by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 27: USA 15-Year Perspective for Mesenchymal Stem Cells
(MSC) by Type - Percentage Breakdown of Value Sales for Human
MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012,
2020 & 2027

Table 28: USA Current & Future Analysis for Mesenchymal Stem
Cells (MSC) by Application - Research Institutes, Hospitals and
Other Applications - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 29: USA Historic Review for Mesenchymal Stem Cells (MSC)
by Application - Research Institutes, Hospitals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 30: USA 15-Year Perspective for Mesenchymal Stem Cells
(MSC) by Application - Percentage Breakdown of Value Sales for
Research Institutes, Hospitals and Other Applications for the
Years 2012, 2020 & 2027

CANADA
Table 31: Canada Current & Future Analysis for Mesenchymal Stem
Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 32: Canada Historic Review for Mesenchymal Stem Cells
(MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 33: Canada 15-Year Perspective for Mesenchymal Stem Cells
(MSC) by Type - Percentage Breakdown of Value Sales for Human
MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012,
2020 & 2027

Table 34: Canada Current & Future Analysis for Mesenchymal Stem
Cells (MSC) by Application - Research Institutes, Hospitals and
Other Applications - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 35: Canada Historic Review for Mesenchymal Stem Cells
(MSC) by Application - Research Institutes, Hospitals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 36: Canada 15-Year Perspective for Mesenchymal Stem Cells
(MSC) by Application - Percentage Breakdown of Value Sales for
Research Institutes, Hospitals and Other Applications for the
Years 2012, 2020 & 2027

JAPAN
Table 37: Japan Current & Future Analysis for Mesenchymal Stem
Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 38: Japan Historic Review for Mesenchymal Stem Cells
(MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 39: Japan 15-Year Perspective for Mesenchymal Stem Cells
(MSC) by Type - Percentage Breakdown of Value Sales for Human
MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012,
2020 & 2027

Table 40: Japan Current & Future Analysis for Mesenchymal Stem
Cells (MSC) by Application - Research Institutes, Hospitals and
Other Applications - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 41: Japan Historic Review for Mesenchymal Stem Cells
(MSC) by Application - Research Institutes, Hospitals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 42: Japan 15-Year Perspective for Mesenchymal Stem Cells
(MSC) by Application - Percentage Breakdown of Value Sales for
Research Institutes, Hospitals and Other Applications for the
Years 2012, 2020 & 2027

CHINA
Table 43: China Current & Future Analysis for Mesenchymal Stem
Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 44: China Historic Review for Mesenchymal Stem Cells
(MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 45: China 15-Year Perspective for Mesenchymal Stem Cells
(MSC) by Type - Percentage Breakdown of Value Sales for Human
MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012,
2020 & 2027

Table 46: China Current & Future Analysis for Mesenchymal Stem
Cells (MSC) by Application - Research Institutes, Hospitals and
Other Applications - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 47: China Historic Review for Mesenchymal Stem Cells
(MSC) by Application - Research Institutes, Hospitals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 48: China 15-Year Perspective for Mesenchymal Stem Cells
(MSC) by Application - Percentage Breakdown of Value Sales for
Research Institutes, Hospitals and Other Applications for the
Years 2012, 2020 & 2027

EUROPE
Table 49: Europe Current & Future Analysis for Mesenchymal Stem
Cells (MSC) by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 50: Europe Historic Review for Mesenchymal Stem Cells
(MSC) by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 51: Europe 15-Year Perspective for Mesenchymal Stem Cells
(MSC) by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2012, 2020 & 2027

Table 52: Europe Current & Future Analysis for Mesenchymal Stem
Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 53: Europe Historic Review for Mesenchymal Stem Cells
(MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 54: Europe 15-Year Perspective for Mesenchymal Stem Cells
(MSC) by Type - Percentage Breakdown of Value Sales for Human
MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012,
2020 & 2027

Table 55: Europe Current & Future Analysis for Mesenchymal Stem
Cells (MSC) by Application - Research Institutes, Hospitals and
Other Applications - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 56: Europe Historic Review for Mesenchymal Stem Cells
(MSC) by Application - Research Institutes, Hospitals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 57: Europe 15-Year Perspective for Mesenchymal Stem Cells
(MSC) by Application - Percentage Breakdown of Value Sales for
Research Institutes, Hospitals and Other Applications for the
Years 2012, 2020 & 2027

FRANCE
Table 58: France Current & Future Analysis for Mesenchymal Stem
Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 59: France Historic Review for Mesenchymal Stem Cells
(MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 60: France 15-Year Perspective for Mesenchymal Stem Cells
(MSC) by Type - Percentage Breakdown of Value Sales for Human
MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012,
2020 & 2027

Table 61: France Current & Future Analysis for Mesenchymal Stem
Cells (MSC) by Application - Research Institutes, Hospitals and
Other Applications - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 62: France Historic Review for Mesenchymal Stem Cells
(MSC) by Application - Research Institutes, Hospitals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 63: France 15-Year Perspective for Mesenchymal Stem Cells
(MSC) by Application - Percentage Breakdown of Value Sales for
Research Institutes, Hospitals and Other Applications for the
Years 2012, 2020 & 2027

GERMANY
Table 64: Germany Current & Future Analysis for Mesenchymal
Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and
Other Types - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 65: Germany Historic Review for Mesenchymal Stem Cells
(MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 66: Germany 15-Year Perspective for Mesenchymal Stem
Cells (MSC) by Type - Percentage Breakdown of Value Sales for
Human MSC, Mouse MSC, Rat MSC and Other Types for the Years
2012, 2020 & 2027

Table 67: Germany Current & Future Analysis for Mesenchymal
Stem Cells (MSC) by Application - Research Institutes,
Hospitals and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 68: Germany Historic Review for Mesenchymal Stem Cells
(MSC) by Application - Research Institutes, Hospitals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 69: Germany 15-Year Perspective for Mesenchymal Stem
Cells (MSC) by Application - Percentage Breakdown of Value
Sales for Research Institutes, Hospitals and Other Applications
for the Years 2012, 2020 & 2027

ITALY
Table 70: Italy Current & Future Analysis for Mesenchymal Stem
Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 71: Italy Historic Review for Mesenchymal Stem Cells
(MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 72: Italy 15-Year Perspective for Mesenchymal Stem Cells
(MSC) by Type - Percentage Breakdown of Value Sales for Human
MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012,
2020 & 2027

Table 73: Italy Current & Future Analysis for Mesenchymal Stem
Cells (MSC) by Application - Research Institutes, Hospitals and
Other Applications - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 74: Italy Historic Review for Mesenchymal Stem Cells
(MSC) by Application - Research Institutes, Hospitals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 75: Italy 15-Year Perspective for Mesenchymal Stem Cells
(MSC) by Application - Percentage Breakdown of Value Sales for
Research Institutes, Hospitals and Other Applications for the
Years 2012, 2020 & 2027

UNITED KINGDOM
Table 76: UK Current & Future Analysis for Mesenchymal Stem
Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 77: UK Historic Review for Mesenchymal Stem Cells (MSC)
by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 78: UK 15-Year Perspective for Mesenchymal Stem Cells
(MSC) by Type - Percentage Breakdown of Value Sales for Human
MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012,
2020 & 2027

Table 79: UK Current & Future Analysis for Mesenchymal Stem
Cells (MSC) by Application - Research Institutes, Hospitals and
Other Applications - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 80: UK Historic Review for Mesenchymal Stem Cells (MSC)
by Application - Research Institutes, Hospitals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 81: UK 15-Year Perspective for Mesenchymal Stem Cells
(MSC) by Application - Percentage Breakdown of Value Sales for
Research Institutes, Hospitals and Other Applications for the
Years 2012, 2020 & 2027

REST OF EUROPE
Table 82: Rest of Europe Current & Future Analysis for
Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC,
Rat MSC and Other Types - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 83: Rest of Europe Historic Review for Mesenchymal Stem
Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other
Types Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 84: Rest of Europe 15-Year Perspective for Mesenchymal
Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales
for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years
2012, 2020 & 2027

Table 85: Rest of Europe Current & Future Analysis for
Mesenchymal Stem Cells (MSC) by Application - Research
Institutes, Hospitals and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 86: Rest of Europe Historic Review for Mesenchymal Stem
Cells (MSC) by Application - Research Institutes, Hospitals and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 87: Rest of Europe 15-Year Perspective for Mesenchymal
Stem Cells (MSC) by Application - Percentage Breakdown of Value
Sales for Research Institutes, Hospitals and Other Applications
for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 88: Asia-Pacific Current & Future Analysis for
Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC,
Rat MSC and Other Types - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 89: Asia-Pacific Historic Review for Mesenchymal Stem
Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other
Types Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 90: Asia-Pacific 15-Year Perspective for Mesenchymal Stem
Cells (MSC) by Type - Percentage Breakdown of Value Sales for
Human MSC, Mouse MSC, Rat MSC and Other Types for the Years
2012, 2020 & 2027

Table 91: Asia-Pacific Current & Future Analysis for
Mesenchymal Stem Cells (MSC) by Application - Research
Institutes, Hospitals and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 92: Asia-Pacific Historic Review for Mesenchymal Stem
Cells (MSC) by Application - Research Institutes, Hospitals and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 93: Asia-Pacific 15-Year Perspective for Mesenchymal Stem
Cells (MSC) by Application - Percentage Breakdown of Value
Sales for Research Institutes, Hospitals and Other Applications
for the Years 2012, 2020 & 2027

REST OF WORLD
Table 94: Rest of World Current & Future Analysis for
Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC,
Rat MSC and Other Types - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 95: Rest of World Historic Review for Mesenchymal Stem
Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other
Types Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 96: Rest of World 15-Year Perspective for Mesenchymal
Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales
for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years
2012, 2020 & 2027

Table 97: Rest of World Current & Future Analysis for
Mesenchymal Stem Cells (MSC) by Application - Research
Institutes, Hospitals and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 98: Rest of World Historic Review for Mesenchymal Stem
Cells (MSC) by Application - Research Institutes, Hospitals and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 99: Rest of World 15-Year Perspective for Mesenchymal
Stem Cells (MSC) by Application - Percentage Breakdown of Value
Sales for Research Institutes, Hospitals and Other Applications
for the Years 2012, 2020 & 2027

IV. COMPETITION
Total Companies Profiled: 47